Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factor-κB signaling

Cancer Research

Volumn 59, Issue 14, 1999, Pages 3299-3303

  Van Hogerlinden, Max ^a   Rozell, Barbro Lundh ^b   Ährlund Richter, Lars ^b   Toftgård, Rune ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; NUCLEAR FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL DEGENERATION; GENE OVEREXPRESSION; HAIR FOLLICLE; HOMEOSTASIS; HYPERPLASIA; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SKIN CANCER; SQUAMOUS CELL CARCINOMA; TRANSGENIC MOUSE; ULTRAVIOLET RADIATION;

ANIMALS; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CROSSES, GENETIC; DNA-BINDING PROTEINS; EPIDERMIS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HAIR DISEASES; HAIR FOLLICLE; HYPERPLASIA; I-KAPPA B PROTEINS; KERATINOCYTES; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, TRANSGENIC; NEOPLASM PROTEINS; NEOPLASMS, RADIATION-INDUCED; NF-KAPPA B; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-REL; RADIATION TOLERANCE; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; TRANSGENES;

EID: 0033565763     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Baldwin, A. S., Jr. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol., 14: 649-683, 1996.
2. Mayo, M. W., Wang, C. Y., Cogswell, P. C., Rogersgraham, K. S., Lowe, S. W., Der, C. J., and Baldwin, A. S. Requirement of NF-κB activation to suppress p53-independent apoptosis induced by oncogenic Ras. Science (Washington DC), 278: 1812-1815, 1997.
3. Tobin, D., van Hogerlinden, M., and Toftgård, R. UVB-induced association of tumor necrosis factor (TNF) receptor 1/TNF receptor-associated factor-2 mediates activation of Rel proteins. Proc. Natl. Acad. Sci. USA, 95: 565-569, 1998.
4. Wang, C. Y., Mayo, M. W., and Baldwin, A. S., Jr. TNF-and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science (Washington DC), 274: 784-787, 1996.
5. Klement, J. F., Rice, N. R., Car, B. D., Abbondanzo, S. J., Powers, G. D., Bhatt, P. H., Chen, C. H., Rosen, C. A., and Stewart, C. L. IκBα deficiency results in a sustained NF-κB response and severe widespread dermatitis in mice. Mol. Cell. Biol., 16: 2341-2349, 1996.
6. Murillas, R., Larcher, F., Conti, C. J., Santos, M., Ullrich, A., and Jorcano, J. L. Expression of a dominant negative mutant of epidermal growth factor receptor in the epidermis of transgenic mice elicits striking alterations in hair follicle development and skin structure. EMBO J., 14: 5216-5223, 1995.
7. Woodcock, A., and Magnus, I. A. The sunburn cell in mouse skin: preliminary quantitative studies on its production. Br. J. Dermatol., 95: 459-468, 1976.
8. Ramirez, A., Bravo, A., Jorcano, J. L., and Vidal, M. Sequences 5′ of the bovine keratin 5 gene direct tissue-and cell-type-specific expression of a lacZ gene in the adult and during development. Differentiation, 58: 53-64, 1994.
9. Brown, K., Gerstberger, S., Carlson, L., Franzoso, G., and Siebenlist, U. Control of IκB-α proteolysis by site-specific, signal-induced phosphorylation. Science (Washington DC), 267: 1485-1488, 1995.
10. Coussens, L. M., Hanahan, D., and Arbeit, J. M. Genetic predisposition and parameters of malignant progression in K14-HPVI6 transgenic mice. Am. J. Pathol., 149: 1899-1917, 1996.
11. Seitz, C. S., Lin, Q., Deng, H., and Khavari, P. A. Alterations in NF-κB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-κB. Proc. Natl. Acad. Sci. USA, 95: 2307-2312, 1998.
12. Zagariya, A., Mungre, S., Lovis, R., Birrer, M., Ness, S., Thimmapaya, B., and Pope, R. Tumor necrosis factor a gene regulation: enhancement of C/EBPβ-induced activation by c-Jun. Mol. Cell. Biol., 18: 2815-2824, 1998.
13. Cheng, J., Turksen, K., Yu, Q. C., Schreiber, H., Teng, M., and Fuchs, E. Cachexia and graft-vs.-host-disease-type skin changes in keratin promoter-driven TNF a transgenic mice. Gene Dev., 6: 1444-1456, 1992.
14. Stern, M. C., Duran, H. A., McKenna, E. A., and Conti, C. J. Increased apoptosis during papilloma development in mice susceptible to tumor progression. Mol. Carcinog., 20: 137-142, 1997.
15. Young, A. R. The sunburn cell. Photo Dermatology, 4: 127-134, 1987.
16. Gilmore, T. D., Koedood, M., Piffat, K. A., and White, D. W. Rel/NF-κB/IκB proteins and cancer. Oncogene, 13: 1367-1378, 1996.
17. Beauparlant, P., Kwan, I., Bitar, R., Chou, P., Koromilas, A. E., Sonenberg, N., and Hiscott, J. Disruption of IκB α regulation by antisense RNA expression leads to malignant transformation. Oncogene, 9: 3189-3197, 1994.
18. Das, K. C., and White, C. W. Activation of NF-κB by antineoplastic agents. Role of protein kinase C. J. Biol. Chem., 272: 14914-14920, 1997.
19. Tobin, D., Nilsson, M., and Toftgård, R. Ras-independent activation of Rel-family transcription factors by UVB and TPA in cultured keratinocytes. Oncogene, 12: 785-793, 1996.
20. Bash, J., Zong, W. X., and Gelinas, C. c-Rel arrests the proliferation of HeLa cells and affects critical regulators of the G1/S-phase transition. Mol. Cell. Biol., 17: 6526-6536, 1997.
21. Coleman, W. B., and Tsongalis, G. J. Multiple mechanisms account for genomic instability and molecular mutation in neoplastic transformation. Clin. Chem., 41: 644-657, 1995.
22. Wrighton, C. J., Hofer-Warbinek, R., Moll, T., Eytner, R., Bach, F. H., and de Martin, R. Inhibition of endothelial cell activation by adenovirus-mediated expression of IκBα, an inhibitor of the transcription factor NF-κB. J. Exp. Med., 183: 1013-1022, 1996.